Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1597955 | 0.81 | SOAT1 (0.44) | CYP2C9MGAMGAASIMGAM2 | |
| SCHEMBL19995249 | 0.81 | SMN1; SMN2 (0.37) | CA1CA2SMN1; SMN2ZDHHC7CA14 | |
| SCHEMBL3525495 | 0.79 | CA1 (0.37) | CA1CA2SMN1; SMN2ZDHHC7CA14 | |
| SCHEMBL7300819 | 0.79 | MGAM (0.42) | CA1CA2SMN1; SMN2ZDHHC7MGAM | |
| SCHEMBL453120 | 0.79 | SMN1; SMN2 (0.50) | CA1CA2SMN1; SMN2ZDHHC7MGAM | |
| SCHEMBL509870 | 0.79 | CYP2C9 (0.40) | CYP2C9SOAT1ALDH1A1TSHR | |
| SCHEMBL1554465 | 0.79 | CA1 (0.46) | CA1CA2ZDHHC7ALDH1A1KMT2A | |
| SCHEMBL18098644 | 0.76 | MGAM (0.44) | CA1CA2SMN1; SMN2ZDHHC7MGAM | |
| SCHEMBL14800513 | 0.76 | CES2 (0.50) | ZDHHC7ALDH1A1TSHRKMT2A | |
| SCHEMBL9834673 | 0.76 | CES2 (0.50) | ZDHHC7ALDH1A1TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121575055-A | Method for efficiently synthesizing 2-chloro-3-oxopentanoic acid methyl ester | 内蒙古华洲药业有限公司 | 2026-02-27 | — | — | CN | claimed |
| CN-111217758-A | Preparation method of 6-ethyl-5-fluoro-4-chloropyrimidine | 湖南复瑞生物医药技术有限责任公司 | 2020-06-02 | — | — | CN | claimed |
| CN-122029166-A | Condensed cyclic compound and harmful arthropod control composition containing the same | 住友化学株式会社 | 2026-05-12 | — | — | CN | disclosed |
| CN-121575055-A | Method for efficiently synthesizing 2-chloro-3-oxopentanoic acid methyl ester | 内蒙古华洲药业有限公司 | 2026-02-27 | — | — | CN | disclosed |
| CN-121575055-A | Method for efficiently synthesizing 2-chloro-3-oxopentanoic acid methyl ester | 内蒙古华洲药业有限公司 | 2026-02-27 | — | — | CN | disclosed |
| CN-121575055-A | Method for efficiently synthesizing 2-chloro-3-oxopentanoic acid methyl ester | 内蒙古华洲药业有限公司 | 2026-02-27 | — | — | CN | disclosed |
| EP-4619104-A1 | BICYCLIC HETEROCYCLES AND THEIR USE AS WRN INHIBITORS | Novartis AG (CH) | 2025-09-24 | — | — | EP | disclosed |
| EP-4601746-A1 | TRICYCLIC COMPOUNDS AND THEIR USES | Novartis AG (CH) | 2025-08-20 | — | — | EP | disclosed |
| EP-4570313-A2 | CYANOTRIAZOLE COMPOUNDS | Otsuka Pharmaceutical Co., Ltd. (JP) | 2025-06-18 | — | — | EP | disclosed |
| CN-120077048-A | Tricyclic compounds and uses thereof | 诺华股份有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120040475-A | Compounds as WRN inhibitors and uses thereof | 南京圣和药业股份有限公司 | 2025-05-27 | — | — | CN | disclosed |
| EP-0708758-B1 | METHOD OF PREPARING 5-CHLORO-4-HYDROXYPYRIMIDINES, 2-CHLORENAMINES AS INTERMEDIATES IN THE METHOD, AND USE OF THE COMPOUNDS THUS PREPARED | HOECHST SCHERING AGREVO GMBH (DE) | 1998-02-04 | — | — | EP | disclosed |
| EP-0761642-A2 | Process for preparing 2-amino-1, 3-alkanediol or a derivative thereof, process for preparing optically active dihydrosphingosine derivatives and intermediates used in that process | Takasago International Corporation (JP) | 1997-03-12 | — | — | EP | disclosed |
| US-5523404-A | Process for preparing 5-chloro-4-hydroxypyrimidines | HOECHST SCHERING AGREVO GMBH (DE) | 1996-06-04 | — | — | US | disclosed |
| EP-0708758-A1 | METHOD OF PREPARING 5-CHLORO-4-HYDROXYPYRIMIDINES, 2-CHLORENAMINES AS INTERMEDIATES IN THE METHOD, AND USE OF THE COMPOUNDS THUS PREPARED | Hoechst Schering AgrEvo GmbH (DE) | 1996-05-01 | — | — | EP | disclosed |
| WO-1995001963-A1 | METHOD OF PREPARING 5-CHLORO-4-HYDROXYPYRIMIDINES, 2-CHLORENAMINES AS INTERMEDIATES IN THE METHOD, AND USE OF THE COMPOUNDS THUS PREPARED | HOECHST SCHERING AGREVO GMBH (DE) | 1995-01-19 | — | — | WO | disclosed |
| EP-0370391-B1 | Process for the preparation of 4,5-dichloro-6-ethyl pyrimidine | LONZA AG (CH) | 1994-11-02 | — | — | EP | disclosed |
| WO-1992006965-A1 | HERBICIDAL SULFONYLUREA DERIVATIVES | ICI AUSTRALIA OPERATIONS PROPRIETARY LIMITED (AU) | 1992-04-30 | — | — | WO | disclosed |
| US-4977264-A | Condensing 2-chloro-3-oxo-pentanoic acid ester with formamidinium salt, reacting with phosphoryl chloride | LONZA LTD. (CH) | 1990-12-11 | — | — | US | disclosed |
| EP-0370391-A2 | Process for the preparation of 4,5-dichloro-6-ethyl pyrimidine | LONZA AG (CH) | 1990-05-30 | — | — | EP | disclosed |